Evidence map›Paper›PMID 23249294›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2013

Single-cell imaging and spectroscopic analyses of Cr(VI) reduction on the surface of bacterial cells.

Yuanmin Wang, Papatya C Sevinc, Sara M Belchik, Jim Fredrickson, Liang Shi, H Peter Lu

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Insights into the Biosynthesis of Nanoparticles by the GenusApplied and environmental microbiology · 2021
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuanmin WangDepartment of Chemistry, Center for Photochemical Sciences, Bowling Green State University, Bowling Green, Ohio 43403, United States.
Papatya C Sevinc
Sara M Belchik
Jim Fredrickson
Liang Shi
H Peter Lu

Funding

In Vivo Characterization of Bacteria-mediated Extracellular Reduction of ChromiumR01ES017070 · NIEHS · BOWLING GREEN STATE UNIVERSITY · PI LU, H PETER · 2009 to 2011
$1.0M
NIEHS NIH HHS 5R01ES017070-03NIEHS NIH HHS R01 ES017070
6 · The paper itself

Abstract

We investigate the single-cell reduction of toxic Cr(VI) by the dissimilatory metal-reducing bacterium Shewanella oneidensis MR-1 (MR-1), an important bioremediation process, using Raman spectroscopy and scanning electron microscopy (SEM) combined with energy-dispersive X-ray spectroscopy (EDX). Our experiments indicate that the toxic, highly soluble Cr(VI) can be efficiently reduced to less toxic, nonsoluble Cr(2)O(3) nanoparticles by MR-1. Cr(2)O(3) is observed to emerge as nanoparticles adsorbed on the cell surface and its chemical nature is identified by EDX imaging and Raman spectroscopy. Co-localization of Cr(2)O(3) and cytochromes by EDX imaging and Raman spectroscopy suggests a terminal reductase role for MR-1 surface-exposed cytochromes MtrC and OmcA. Our experiments revealed that the cooperation of surface proteins OmcA and MtrC makes the reduction reaction most efficient, and the sequence of the reducing reactivity of MR-1 is wild type > single mutant ΔmtrC or mutant ΔomcA > double mutant (ΔomcA-ΔmtrC). Moreover, our results also suggest that direct microbial Cr(VI) reduction and Fe(II) (hematite)-mediated Cr(VI) reduction mechanisms may coexist in the reduction processes.

Indexed as

Chromium CompoundsCytochrome c GroupMicroscopy, Electron, ScanningNanoparticlesOxidation-ReductionShewanellaSpectrometry, X-Ray EmissionSpectrum Analysis, RamanSurface Propertieschromic oxideChromium CompoundsCytochrome c Group

Identifiers

PMID23249294
PMCPMC3671764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.